Sensome

About

Sensome is a clinical-stage healthtech startup founded in 2014 in France, focusing on innovative microsensor technology. The company specializes in integrating impedance-based sensors with machine learning algorithms to provide real-time insights into biological tissues during minimally invasive procedures. Sensome develops connected medical devices that enhance traditional tools, offering physicians valuable patient-specific information for improved decision-making in interventional medicine. One of Sensome's primary products is the Clotild® Smart Guidewire System, designed for treating acute ischemic stroke. This tissue-sensing guidewire aids in clot removal by identifying clot characteristics upon contact. The company is also exploring additional applications in neurovascular, peripheral vascular, and oncology fields. Sensome is actively pursuing partnerships for device design, manufacturing, and distribution, collaborating with industry leaders like Asahi Intecc and Cosmotec to advance its technology through regulatory processes.